We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$3.29B
AUM Growth
+$322M
Cap. Flow
+$111M
Cap. Flow %
3.39%
Top 10 Hldgs %
10.67%
Holding
1,133
New
146
Increased
560
Reduced
374
Closed
47

Top Buys

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$18.1M
2
AAPL icon
Apple
AAPL
+$9.12M
3
ABBV icon
AbbVie
ABBV
+$8.74M
4
META icon
Meta Platforms (Facebook)
META
+$7.28M
5
CMCSA icon
Comcast
CMCSA
+$7.16M

Sector Composition

Rank Sector Weight
1 Technology 29.68%
2 Healthcare 14.09%
3 Energy 12.28%
4 Industrials 10.52%
5 Consumer Discretionary 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
526
Altria Group
MO
$114B
$1.48M 0.05%
31,106
+4,199
+16% +$206K
ESTC icon
527
Elastic
ESTC
$7.81B
$1.48M 0.05%
10,166
+1,878
+23% +$235K
HPP
528
Hudson Pacific Properties
HPP
$779M
$1.48M 0.05%
7,610
+186
+3% +$36.8K
LXP icon
529
LXP Industrial Trust
LXP
$3.57B
$1.48M 0.05%
24,809
+605
+2% +$36.8K
FORM icon
530
FormFactor
FORM
$9.17B
$1.47M 0.04%
40,392
-1,236
-3% -$48.7K
NNN icon
531
NNN REIT
NNN
$8.99B
$1.47M 0.04%
31,377
+732
+2% +$34.3K
DOC icon
532
Healthpeak Properties
DOC
$14.8B
$1.47M 0.04%
44,039
+910
+2% +$30.5K
FTI icon
533
TechnipFMC
FTI
$27.3B
$1.47M 0.04%
161,824
-639
-0.4% -$5.4K
GMAB icon
534
Genmab
GMAB
$19.5B
$1.46M 0.04%
35,793
-6,260
-15% -$242K
STT icon
535
State Street
STT
$50.7B
$1.45M 0.04%
17,622
+12,218
+226% +$1.03M
RUBY
536
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.45M 0.04%
+59,286
New +$1.48M
XNCR icon
537
Xencor
XNCR
$1.55B
$1.45M 0.04%
41,933
+3,841
+10% +$152K
WERN icon
538
Werner Enterprises
WERN
$2.25B
$1.44M 0.04%
32,402
-993
-3% -$46.4K
ZYME icon
539
Zymeworks
ZYME
$1.67B
$1.44M 0.04%
41,554
+10,386
+33% +$330K
VRSN icon
540
VeriSign
VRSN
$26.6B
$1.44M 0.04%
6,326
-2
-0% -$435
DXCM icon
541
DexCom
DXCM
$32B
$1.44M 0.04%
13,440
-8,152
-38% -$783K
CHKP icon
542
Check Point Software Technologies
CHKP
$13.1B
$1.43M 0.04%
12,339
-1,044
-8% -$123K
LILAK icon
543
Liberty Latin America Class C
LILAK
$1.64B
$1.43M 0.04%
111,596
-3,416
-3% -$43.8K
DDOG icon
544
Datadog
DDOG
$84B
$1.43M 0.04%
13,729
+3,971
+41% +$359K
MKTX icon
545
MarketAxess Holdings
MKTX
$5.72B
$1.43M 0.04%
3,075
-602
-16% -$287K
PFPT
546
DELISTED
Proofpoint, Inc.
PFPT
$1.42M 0.04%
8,180
-194
-2% -$31.5K
APH icon
547
Amphenol
APH
$209B
$1.41M 0.04%
+41,120
New +$1.39M
YMAB
548
DELISTED
Y-mAbs Therapeutics
YMAB
$1.41M 0.04%
41,609
+10,170
+32% +$326K
KBH icon
549
KB Home
KBH
$3.59B
$1.4M 0.04%
34,371
-1,053
-3% -$48.6K
ALXO icon
550
ALX Oncology
ALXO
$290M
$1.4M 0.04%
25,591
+11,020
+76% +$659K

Similar funds

Vident Investment Advisory's Q2 2021 Portfolio in Review

As of Q2 2021, Vident Investment Advisory held 1,133 positions worth $3.29B, up 11% from $2.97B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Vident Investment Advisory deployed $111M of net new capital in Q2 2021, opening 146 new positions and adding to 560 existing holdings. Its largest new stake was XPO: 59,887 shares worth $2.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Nuance Communications, Inc., an estimated $29.7M trimmed.

  • Vident Investment Advisory's largest Q2 2021 buy was XPO: 59,887 shares worth $2.9M.
  • Vident Investment Advisory added most to iRhythm Holdings in Q2 2021, an estimated $18.1M increase.
  • Vident Investment Advisory's biggest Q2 2021 reduction was Nuance Communications, Inc., cutting an estimated $29.7M.
  • Vident Investment Advisory fully exited Cooper Tire & Rubber Co. in Q2 2021, selling an estimated $2.79M.
  • Vident Investment Advisory's ten largest holdings make up 11% of its $3.29B portfolio in Q2 2021.
  • Vident Investment Advisory opened 146 new positions and closed 47 in Q2 2021.
  • Vident Investment Advisory's portfolio value rose 11% quarter-over-quarter to $3.29B.

Based on Vident Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.